Abstract

Differences in health risks between different styles of smokeless tobacco products (STPs) have prompted interest in their relative levels of toxic chemicals. We report here the development of methods for the analysis of STPs for coumarin and for α-angelica lactone (α-AL), both of which have been included in various published lists of tobacco toxicants. We have also determined the concentrations of these lactones in commercial STPs from the US and Sweden, representing 80–90% of the 2010 market share for all the major STP categories in these two countries: 65 products (plus two reference products) for coumarin and 66 commercial products for α-AL. For coumarin, methanol extracts of the STPs were analysed by HPLC/MS/MS. The lower limit of quantification (LOQ) and limit of detection (LOD) were, respectively, 100 and 30 ng coumarin/g of STP on a wet weight basis (WWB). Alpha-AL was determined via direct headspace GC/MS. The LOQ and LOD were 65 and 30 ng/g WWB respectively. Coumarin was detected In 3/33 Swedish snus, 5/13 US chewing tobaccos, 16/16 moist snuffs and 5/6 dry snuffs. Concentrations in those samples with quantifiable coumarin contents ranged from 186 to 1656 ng/g WWB. Concentrations of coumarin measured in this study were consistent with levels naturally found in tobacco. None of the STPs analysed would significantly contribute to coumarin exposure in consumers compared with dietary sources, and estimated exposure levels were 1000× lower than the European Food Safety Authority Tolerable Daily Intake. Hence the relevance of coumarin to the toxicity of STPs and its inclusion in the FDA’s list of harmful and potentially harmful compounds list is questionable. Measurements of α-AL in these STPs found that the majority did not have quantifiable contents, however, for three STPs concentrations of α-AL were above the LOQ (116–140 ng/g WWB) and for four other STPs concentrations of α-AL could be estimated between the LOD and LOQ. Beta-angelica lactone was tentatively identified in three of the STPs but the levels could not be reliably quantified. The levels of α-AL in tobacco products are reported here for the first time, but the relevance of α-AL to the toxicity of STPs is also highly questionable given that it has GRAS status as a permitted food additive.

Highlights

  • Differences in health risks between different styles of smokeless tobacco products (STPs) have prompted interest in their relative levels of toxic chemicals

  • Sources of coumarin in tobacco Given the differing levels of coumarin between STP styles, and in some cases within styles, the question arises as to whether the levels are intrinsic to the tobaccos used in the product or whether flavour materials containing coumarin have been added

  • In this study a wide range of STPs from Sweden and the US were analysed for the lactones coumarin and angelica lactones

Read more

Summary

Introduction

Differences in health risks between different styles of smokeless tobacco products (STPs) have prompted interest in their relative levels of toxic chemicals. The International Agency for Research on Cancer (IARC), has collectively designated STPs as Group 1 carcinogens, i.e. carcinogenic to humans [1], evidence has been accumulating that health risks differ between STP categories Some product styles such as Swedish snus and American CT have been shown to have lower health risks associated with their use [2] than other styles. The US Food and Drug Administration (FDA) has assembled a list of 93 harmful and potentially harmful constituents (HPHC) of tobacco products which may have to be reported [8]. This list covers both tobacco and tobacco smoke components and includes 79 that are designated as carcinogenic, as well as constituents that are respiratory toxicants, cardiovascular toxicants, reproductive toxicants or addictive. Tobacco itself naturally contains coumarin [17,18,19,20] at relatively low levels (generally < 1 ppm), firecured tobacco has been reported to contain higher levels of coumarin than other tobacco types [17]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call